BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18445134)

  • 1. Conformational change of the transmembrane helices II and IV of metabotropic glutamate receptor involved in G protein activation.
    Yamashita T; Terakita A; Kai T; Shichida Y
    J Neurochem; 2008 Jul; 106(2):850-9. PubMed ID: 18445134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel constitutively active mutation in the second cytoplasmic loop of metabotropic glutamate receptor.
    Yamashita T; Kai T; Terakita A; Shichida Y
    J Neurochem; 2004 Oct; 91(2):484-92. PubMed ID: 15447681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation switch in the transmembrane domain of metabotropic glutamate receptor.
    Yanagawa M; Yamashita T; Shichida Y
    Mol Pharmacol; 2009 Jul; 76(1):201-7. PubMed ID: 19398535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
    Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
    Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory role of C-terminus in the G-protein coupling of the metabotropic glutamate receptor 1.
    Tateyama M; Kubo Y
    J Neurochem; 2008 Nov; 107(4):1036-46. PubMed ID: 18786167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of the extracellular regions of the group II/III metabotropic glutamate receptors.
    Muto T; Tsuchiya D; Morikawa K; Jingami H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3759-64. PubMed ID: 17360426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids involved in conformational dynamics and G protein coupling of an odorant receptor: targeting gain-of-function mutation.
    Kato A; Katada S; Touhara K
    J Neurochem; 2008 Dec; 107(5):1261-70. PubMed ID: 18803693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate acts as a partial inverse agonist to metabotropic glutamate receptor with a single amino acid mutation in the transmembrane domain.
    Yanagawa M; Yamashita T; Shichida Y
    J Biol Chem; 2013 Apr; 288(14):9593-9601. PubMed ID: 23420844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acids at two dimer interface regions of the alpha-factor receptor (Ste2).
    Wang HX; Konopka JB
    Biochemistry; 2009 Aug; 48(30):7132-9. PubMed ID: 19588927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse functional motifs within the three intracellular loops of the CGRP1 receptor.
    Conner AC; Simms J; Conner MT; Wootten DL; Wheatley M; Poyner DR
    Biochemistry; 2006 Oct; 45(43):12976-85. PubMed ID: 17059214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist-induced conformational changes in thyrotropin-releasing hormone receptor type I: disulfide cross-linking and molecular modeling approaches.
    Huang W; Osman R; Gershengorn MC
    Biochemistry; 2005 Feb; 44(7):2419-31. PubMed ID: 15709754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F.
    Sheikh SP; Zvyaga TA; Lichtarge O; Sakmar TP; Bourne HR
    Nature; 1996 Sep; 383(6598):347-50. PubMed ID: 8848049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction.
    Reis RI; Santos EL; Pesquero JB; Oliveira L; Schanstra JP; Bascands JL; Pecher C; Paiva AC; Costa-Neto CM
    Regul Pept; 2007 Apr; 140(1-2):32-6. PubMed ID: 17239455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the integral membrane domain of the GLP1 receptor.
    Frimurer TM; Bywater RP
    Proteins; 1999 Jun; 35(4):375-86. PubMed ID: 10382665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of a kappa opioid receptor devoid of all free cysteines.
    Ott D; Frischknecht R; Plückthun A
    Protein Eng Des Sel; 2004 Jan; 17(1):37-48. PubMed ID: 14985536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How do G-protein-coupled receptors work? The case of metabotropic glutamate and GABA receptors].
    Galvez T; Pin JP
    Med Sci (Paris); 2003 May; 19(5):559-65. PubMed ID: 12836389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional complementation and the analysis of opioid receptor homodimerization.
    Pascal G; Milligan G
    Mol Pharmacol; 2005 Sep; 68(3):905-15. PubMed ID: 15967873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divalent cations modulate the activity of metabotropic glutamate receptors.
    Francesconi A; Duvoisin RM
    J Neurosci Res; 2004 Feb; 75(4):472-9. PubMed ID: 14743430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predisposition of the dark state of rhodopsin to functional changes in structure.
    Isin B; Rader AJ; Dhiman HK; Klein-Seetharaman J; Bahar I
    Proteins; 2006 Dec; 65(4):970-83. PubMed ID: 17009319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.